ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Preparing for its next phase of growth and the launch of the first of six products currently in their pipeline, Exagen Diagnostics, Inc. announced today that David P. Becker, a seasoned merger and acquisition consultant, joined the biotech company's Board of Directors.
